NJ State Employees Deferred Compensation Plan’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-5,180
| Closed | -$726K | – | 52 |
|
|
2025
Q3 | $726K | Buy |
5,180
+2,680
| +107% | +$362K | 0.08% | 233 |
|
|
2025
Q2 | $314K | Hold |
2,500
| – | – | 0.04% | 342 |
|
|
2025
Q1 | $342K | Hold |
2,500
| – | – | 0.04% | 337 |
|
|
2024
Q4 | $382K | Hold |
2,500
| – | – | 0.05% | 333 |
|
|
2024
Q3 | $485K | Hold |
2,500
| – | – | 0.06% | 298 |
|
|
2024
Q2 | $580K | Hold |
2,500
| – | – | 0.07% | 257 |
|
|
2024
Q1 | $539K | Hold |
2,500
| – | – | 0.07% | 270 |
|
|
2023
Q4 | $647K | Hold |
2,500
| – | – | 0.09% | 237 |
|
|
2023
Q3 | $643K | Hold |
2,500
| – | – | 0.1% | 215 |
|
|
2023
Q2 | $712K | Hold |
2,500
| – | – | 0.1% | 210 |
|
|
2023
Q1 | $695K | Hold |
2,500
| – | – | 0.11% | 213 |
|
|
2022
Q4 | $692K | Hold |
2,500
| – | – | 0.11% | 195 |
|
|
2022
Q3 | $668K | Hold |
2,500
| – | – | 0.11% | 195 |
|
|
2022
Q2 | $510K | Hold |
2,500
| – | – | 0.08% | 253 |
|
|
2022
Q1 | $527K | Hold |
2,500
| – | – | 0.07% | 284 |
|
|
2021
Q4 | $600K | Hold |
2,500
| – | – | 0.08% | 259 |
|
|
2021
Q3 | $707K | Hold |
2,500
| – | – | 0.1% | 221 |
|
|
2021
Q2 | $866K | Buy |
2,500
+1,500
| +150% | +$454K | 0.12% | 196 |
|
|
2021
Q1 | $280K | Hold |
1,000
| – | – | 0.04% | 417 |
|
|
2020
Q4 | $245K | Hold |
1,000
| – | – | 0.04% | 419 |
|
|
2020
Q3 | $284K | Hold |
1,000
| – | – | 0.05% | 334 |
|
|
2020
Q2 | $268K | Hold |
1,000
| – | – | 0.05% | 349 |
|
|
2020
Q1 | $316K | Hold |
1,000
| – | – | 0.07% | 272 |
|
|
2019
Q4 | $297K | Hold |
1,000
| – | – | 0.05% | 399 |
|
|
2019
Q3 | $233K | Hold |
1,000
| – | – | 0.04% | 448 |
|
|
2019
Q2 | $234K | Hold |
1,000
| – | – | 0.04% | 491 |
|
|
2019
Q1 | $236K | Sell |
1,000
-2,000
| -67% | -$630K | 0.04% | 489 |
|
|
2018
Q4 | $903K | Hold |
3,000
| – | – | 0.19% | 118 |
|
|
2018
Q3 | $1.06M | Buy |
+3,000
| New | +$1.03M | 0.18% | 122 |
|
|
2016
Q3 | – | Sell |
-7,000
| Closed | -$1.69M | – | 367 |
|
|
2016
Q2 | $1.69M | Hold |
7,000
| – | – | 0.36% | 76 |
|
|
2016
Q1 | $1.96M | Hold |
7,000
| – | – | 0.42% | 62 |
|
|
2015
Q4 | $2.14M | Hold |
7,000
| – | – | 0.44% | 53 |
|
|
2015
Q3 | $2.04M | Buy |
+7,000
| New | +$2.31M | 0.44% | 55 |
|
Other funds holding BIIB
NJ State Employees Deferred Compensation Plan's BIIB Position: Q4 2025 in Review
NJ State Employees Deferred Compensation Plan sold out of Biogen (BIIB) in Q4 2025, closing a stake of 5,180 shares — an estimated $726K sold.
NJ State Employees Deferred Compensation Plan first reported a position in BIIB in Q3 2015 and held it in 33 quarters. The position peaked at $2.14M in Q4 2015. 998 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.
- NJ State Employees Deferred Compensation Plan reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
- NJ State Employees Deferred Compensation Plan sold 5,180 Biogen shares in Q4 2025, an estimated $726K.
- NJ State Employees Deferred Compensation Plan first reported a position in Biogen in Q3 2015 and held it in 33 quarters.
- NJ State Employees Deferred Compensation Plan's Biogen position peaked at $2.14M in Q4 2015.
- 998 funds tracked by Wall St. Rank held Biogen as of Q4 2025.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.